Yes Securities recently issued a Reduce Call on Dr. Lal Pathlabs, along with a new Target Price for the company. Now, let’s examine the research reports and explore their overviews.
Dr. Lal Pathlabs is a leading diagnostic healthcare service provider in India. Established in 1949 by Dr. S.K. Lal, the company has grown into a trusted and renowned name in the industry. With a vast network of laboratories across the country, Dr. Lal Pathlabs offers a comprehensive range of diagnostic and pathology services.
Dr. Lal Pathlabs is a leading player in the diagnostic healthcare sector, known for its extensive range of services, cutting-edge technology, and commitment to delivering accurate and reliable results.
|Name||Dr. Lal Pathlabs|
|Type||Diagnostic healthcare service provider|
|Profile on Wikipedia||Dr. Lal Pathlabs on Wikipedia|
Dr. Lal Pathlabs’s current market price is Rs 1996 with a market capitalization of Rs 16411.80 Crore. Recently, Yes Securities issued a Reduce Call on Dr. Lal Pathlabs with a new Target Price of Rs 1875.
After making slight adjustments to the FY24 and FY25 estimates, the analysis suggests a “reduce” rating for the company. The revised target price is set at Rs 1,875. This indicates a bearish sentiment towards the stock, potentially due to factors such as projected earnings growth, industry dynamics, or company-specific challenges. Investors may consider reducing their exposure to the stock based on this analysis.
However, additional information or analysis is needed to fully understand the rationale behind the “reduce” rating and the factors driving the revised target price
Consolidated Total Income
In the latest quarter, the company recorded a consolidated total income of Rs 505.20 Crore, showing a marginal increase of 1.06% compared to the previous quarter and a slight growth of 1.55% compared to the same quarter last year.
This indicates a relatively stable revenue performance. Additionally, the company achieved a net profit after tax of Rs 56.90 Crore in the latest quarter, reflecting profitability. While the growth rates are modest, it suggests the company’s ability to maintain its financial stability and generate consistent profits.
As of 31-03-2023, the company has a total of 8 Crore shares outstanding. Shares outstanding refers to the total number of shares issued by the company and held by investors.
Here’s a table summarizing the ownership structure of the company as of 31-Mar-2023
|Foreign Institutional Investors (FIIs)||24.89|
|Domestic Institutional Investors (DIIs)||6.56|
Disclaimer:– This share price target price should not be taken as a guarantee or prediction of future stock performance, nor should it be considered as investment advice.
We strongly advise investors to conduct their own research and analysis before making any investment decisions and to seek the advice of a financial advisor if necessary. Sharedhan.com or its representatives shall not be held liable for any losses or damages incurred as a result of reliance on this share price target price.